Our cookie policy | We use cookies to ensure you get the best experience on our website.
accept & close read more
Please log in to Ortho Plus Instructions for Use Library
  • Ortho Clinical Diagnostics

  • Solutions
    • Improve Lab Performance

      Maximize staff productivity and system performance while reducing errors

    • Achieve Cost Management

      Lower costs with accurate financial tracking across your lab

    • Enhance Clinical Outcomes

      Deliver accuracy and consistency of results to enhance patient care

    • Overcome Staffing Challenges

      Make more efficient use of staff's time to attract and retain it

    • or Browse Our Products & Services
    • Integrated Products

    • VITROS® XT 7600 Integrated System

    • VITROS® 5600 Integrated System

    • Chemistry Products

    • VITROS® XT 3400 Chemistry System

    • VITROS® 4600 Chemistry System

    • Immunodiagnostic Products

    • VITROS® 3600 Immunodiagnostic System

    • VITROS® ECiQ Immunodiagnostic System

    • or Browse by Solutions
    • ORTHO CARE™ Overview

      Get the support you need to make more informed decisions

    • Lab Reliability

      Provide your patients with predictable, reliable results

    • Lab Optimization

      Uncover information and workflow bottlenecks with our ValuMetrix™ teams

    • Training & Education

      Help your lab gain greatly enhanced operational efficiency

    • or Browse by Solutions
    • Lab Automation

    • VITROS® Automation Solutions

      Gain real benefits with automated, streamlined, and standardized workflow

    • Menu of assays

    • VITROS® Menu of Assays

      Our world-class immunoassays span all major disease categories

    • MicroTip Partnership Assays

      Validated third party assays

    • Data management

    • Informatics

      Increase security, optimize labor, and contain costs

    • or Browse by Solutions
    • Integration Product Portfolio

      Learn how our solutions can help you overcome today’s challenges

    • Full Automation

      Drive lab efficiency with solutions that automate over 99% of the labs’ daily workload

    • Semi Automation

      Ensure high quality performance and results right sized for your needs

    • Data/Workflow

      Utilize Intelligent solutions to help maximize productivity and full lab efficiency

    • Menu

      Maximize efficiency with a comprehensive testing menu that is flexible to your workflow needs  

    • or Browse by Solutions
    • Assay Portfolio

    • Reagents

      Leverage the comprehensive power of Ortho’s trusted testing menu

    • ORTHO Sera

      Expect more from extended phenotype testing

    • Lab Management

    • ORTHO CONNECT

      Taking lab productivity to the next level

    • or Browse by Solutions
    • Chemistry and immunodiagnostics

    • VITROS® Family of Systems

      Learn how our diagnostic solutions can help you inform more than 70% of all medical decisions

    • Assay Portfolio, Automation & Data Management

      Our world-class immunoassays, open automation and data management portfolio provide actionable diagnostic insights

    • Transfusion Medicine

    • Immunohematology

      The only instrumentation platform with the most diverse testing capabilities available.

    • Donor Screening

      Deliver accuracy and consistency of results to enhance patient care

    • Support

    • ORTHO CARE™

      Ortho's holistic support model to facilitate high quality patient care

    • or Browse by Solutions
  • About
    • Innovations

      For more than 75 years, Ortho has pioneered life-impacting advances

    • Responsibility

      Our commitment to patients, the planet and healthcare industry

    • Our Story

      Discover important moments throughout our rich history of pioneering life-impacting advances.

    • Careers

      At Ortho, we recruit the best and brightest around the world

  • Resources
    • News & Events

      Read about recent news and events at Ortho

    • Learn

      Watch compelling perspectives on hot industry topics from Ortho ON Demand contributors

    • Evidence

      Access case studies, white papers, customers' success stories and more

    • Technical Documents

      Download technical documents, IFUs, MSDS, Specs, Control Assay Sheets, Maintenance Logs and more

  • Investors
  • Contact

Ortho Clinical Diagnostics

Home
Toggle Search
Search
INT
  • Argentina
  • Australia
  • Belgium
  • Bolivia
  • Brazil
  • Canada
  • Canada - Français
  • Chile
  • China
  • Colombia
  • Costa Rica
  • Dominican Republic
  • Ecuador
  • El Salvador
  • France
  • Germany
  • Guatemala
  • Honduras
  • Hong Kong SAR
  • India
  • Italy
  • Japan
  • Mexico
  • Netherlands
  • New Zealand
  • Nicaragua
  • Panama
  • Peru
  • Puerto Rico
  • Scandinavia
  • South Korea
  • United Kingdom
  • Uruguay
  • Venezuela
  • Solutions
  • About
  • Resources
  • Investors
  • Contact
  • Innovations
  • Responsibility
  • Our Story
  • Careers
  • News & Events
  • Learn
  • Evidence
  • Technical Documents
  • Improve Lab Performance
  • Achieve Cost Management
  • Enhance Clinical Outcomes
  • Overcome Staffing Challenges
  • Or Browse Our Products & services
  • Integrated Products

  • VITROS® XT 7600 Integrated System
  • VITROS® 5600 Integrated System
  • Chemistry Products

  • VITROS® XT 3400 Chemistry System
  • VITROS® 4600 Chemistry System
  • Immunodiagnostic Products

  • VITROS® 3600 Immunodiagnostic System
  • VITROS® ECiQ Immunodiagnostic System
  • Lab Automation

  • VITROS® Automation Solutions
  • Menu of assays

  • VITROS® Menu of Assays
  • MicroTip Partnership Assays
  • Data management

  • Informatics
  • Integration Product Portfolio
  • Full Automation
  • Semi Automation
  • Data/Workflow
  • Menu
  • Assay Portfolio

  • Reagents
  • ORTHO Sera
  • Lab Management

  • ORTHO CONNECT
  • Chemistry and immunodiagnostics

  • VITROS® Family of Systems
  • Assay Portfolio, Automation & Data Management
  • Transfusion Medicine

  • Immunohematology
  • Donor Screening
  • Support

  • ORTHO CARE™
Please log in to Ortho Plus Instructions for Use Library
  1. Homepage
  2. Resources
  3. News & Events
  4. Press Release
01/12/2021

Ortho’s VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First Widely-Available High-Volume Test to Receive FDA Emergency Use Authorization

  • Ortho’s VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA).
  • With utility for mass-scale testing and same-day results for labs, Ortho’s latest COVID-19 solution can run up to 130 tests per hour.
  • The test is run on Ortho’s high-volume VITROS® Systems, which are installed in over 5,600 laboratories around the world with 1,500 installed in the U.S.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its VITROS® SARS-CoV-2 Antigen Test, designed to detect active infection, has become the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA). U.S. distribution of the test commenced in November 2020 under an FDA Emergency Use Notification (EUN); the test was also granted CE Mark in November 2020. 

Ortho’s antigen test comes at a critical time—a recent Rockefeller Foundation report estimates that the U.S. will need to increase coronavirus testing capacity by nearly 10-fold -- from 21 million to 193 million tests per month -- in order to reopen schools safely and protect nursing homes.  

With utility for mass-scale testing and same-day results for labs, Ortho’s latest COVID-19 solution can run up to 130 tests per hour and immediately help hospitals and reference labs address testing backlogs, supply shortages, and delayed results. 

“As the pandemic continues to devastate our communities and economy, laboratory professionals have been working under extraordinary circumstances to deliver critical COVID-19 testing data to patients, clinicians and communities,” said Chris Smith, chairman and chief executive officer, Ortho Clinical Diagnostics. “Even as vaccine inoculation programs roll out, mass-scale testing remains an essential tool in fighting COVID-19. Ortho’s accurate, high-volume COVID-19 antigen test can play a pivotal role in the global response to this virus.”  

About the VITROS® SARS-CoV-2 Antigen Test


The VITROS® SARS-CoV-2 Antigen Test produces accuratei, clinically reliable results on Ortho’s high-volume VITROS® Systems, which are installed in over 5,600 laboratories around the world. More than 1,500 VITROS analyzers are operational across the U.S. – including more than 500 located in rural regions, where coronavirus testing needs are especially urgent. 


These analyzers normally run a broad menu of over 150 different tests from blood and body fluid samples, but now are also able to run samples derived from swabs. Additional analyzers are available for shipment and can be installed rapidly to further increase capacity since they don’t require an external water source to operate.


Ortho’s COVID-19 antigen test is an alternative to real-time polymerase chain reaction (PCR) testing, which although highly sensitive, can be expensive and require long processing times during testing surges. Roughly one-third of individuals who underwent a PCR test waited more than four days for a result—including 10% who waited more than 10 days, according to an article published by researchers from Harvard, Northeastern, Northwestern, and Rutgers.ii


Other COVID-19 diagnostic testing platforms, including rapid antigen tests, have limited capacity to run multiple tests simultaneously or require short time windows to read results, making it challenging to test more than a handful of patients at a time.  


Ortho is currently able to deliver 5 million tests per month and can scale up to 15 million tests per month in February.


About Ortho’s VITROS® COVID-19 Testing Solutions


Ortho’s new SARS-CoV-2 Antigen Test is the latest addition to the company’s COVID-19 solutions, which include two COVID-19 antibody tests — Total and IgG — both of which have FDA EUA and CE Mark. 


Because Ortho’s VITROS Systems are already installed worldwide, reporting times may be further improved because lab staff require no additional training, and the instruments are already connected to existing laboratory information systems and software. These systems are self-contained and do not require an external water source to run.


Questions from laboratories, health care providers, or government officials regarding Ortho’s COVID-19 solutions can be directed to: OrthoCOVID19Test@orthoclinicaldiagnostics.com. For more information visit: https://www.orthoclinicaldiagnostics.com/global/covid19/. 


This project has been funded with federal funds from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response under Contract No. 75A50120P00103.


The VITROS SARS-CoV-2 Antigen Test has not been FDA cleared or approved. It has been authorized by the FDA under an Emergency Use Authorization and testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform moderate or high complexity tests. This test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.


The VITROS Anti-SARS-CoV-2 Total and IgG tests have not been FDA cleared or approved.They have been authorized by the FDA under an Emergency Use Authorization and testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform moderate or high complexity tests. The VITROS Antibody tests have been authorized only for the detection of either Total or IgG antibodies from SARS-CoV-2, not for any other viruses or pathogens, and results should not be used as the sole basis for diagnosis. These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.





i Sensitivity: 80.0% (95% CI: 56.6–88.5%) Specificity: 100.0% (95% CI: 95.2–100.0%)
ii Lazer, David. The COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States. Northeastern University, Harvard University, Rutgers University, and Northwestern University.

Press contact

For media inquiries please contact

Ortho Media Relations Ortho Clinical Diagnostics media@orthoclinicaldiagnostics.com (+1) 908 704 8256

{}
  • ${title}${badge}
${loading}

Footer

  • Contact
  • Careers
  • Ortho Plus
  • Technical Documents
  • Chemistry and Immunodiagnostics

    • VITROS® XT 7600 Integrated System
    • VITROS® 5600 Integrated System
    • VITROS® 4600 Chemistry System
    • VITROS® XT 3400 Chemistry System
    • VITROS® 3600 Immunodiagnostic System
    • VITROS® ECiQ Immunodiagnostic System
    • VITROS® Automation Solutions
    • Informatics Solutions
    • Assay Menu by Disease State
    • Microtip Partnership Assays
    • VITROS® HIV Combo Test
    • VITROS® B•R•A•H•M•S PCT Assay
  • Transfusion Medicine

    • ORTHO VISION® Analyzer
    • ORTHO VISION® Max Analyzer
    • ORTHO CONNECT™
    • ORTHO™ Workstation
  • Service and Support

    • Lab Reliability
    • Lab Optimization
    • Training & Education
    • Lab Support
  • Privacy Notice
  • Legal Notice
  • Patents
  • Cookie Notice & Disclosure
  • Declaration for California Compliance for Healthcare Providers
  • Our Code of Conduct
  • Cybersecurity
Ⓒ 2021 Ortho Clinical Diagnostics. Ortho Clinical Diagnostics, publishes this site and is solely responsible for its content. The availability of the products is subject to compliance with the regulatory requirements of each market.
*This website contains information which is targeted to a wide range of audiences and could contain product details or information otherwise not valid or applicable to your country. Please remember to consult your local legal restrictions, regulations, registrations or intended uses in the country of your origin. Product availability may vary from country to country and is subject to varying regulatory requirements.

Not currently available in the USA

Why subscribe to Premium content?

Enjoy unlimited access to the very best insights across the diagnostic community including industry reports and regular webinars from thought leaders.

  • Trusted opinion
  • Tailored to you
  • It’s FREE

Sign up for Free!

  • Access to Premium resources
  • Premium Rewards including offers, competitions and events exclusives
  • Premium subscriber-only newsletters and briefings

Already a user?

Log In

Welcome Back

Unable to locate the email. Click here to register or try again.

Welcome!

Premium accounts are completely free and give you unrestricted access to Ortho’s Technical Documents and many more exclusive content! Just fill in the form.

Already a user?

Log In